The FDA has approved ODACTRA®, an under-the-tongue immunotherapy tablet, for treating house dust mite allergies in children aged 5-11 years, expanding its previous indication for ages 12-65.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.